Synthetic affinity-based probes for ADP-Ribose interactome studies

Adenosine diphosphate ribosylation (ADP-ribosylation) is a fascinating post-translational modification (PTM) that plays a role in a variety of cellular processes and is associated with several diseases, including cancer and viral infections. To understand this PTM in more detail and consequently develop effective drugs based on this information, it is essential to investigate the key proteins involved in ADP-ribosylation: ADP-ribosyltransferases (<i>writers</i>), hydrolases (<i>erasers</i>), and the proteins interacting with ADP-ribose (<i>readers</i>). Much past and current research has examined proteins that function as the writers and erasers of ADP-ribosylation. This research has led to the development of anti-cancer drugs, such as olaparib, and advancements towards future antiviral therapies targeting COVID-19. However, there is also significant potential in exploring the readers of ADP-ribosylation, as they regulate many downstream processes related to ADP-ribosylated proteins and may present valuable therapeutic targets. To gain a better understanding of the readers of ADP-ribose as post-translational modification, it is essential to identify which proteins specifically interact with each of the various forms of ADP-ribose, including mono-ADP-ribose, linear poly-ADP-ribose, and branched poly-ADP-ribose. Well-defined synthetic ADP-ribose derivatives serve as ideal molecular probes in proteomics studies, allowing clear differentiation between the different forms of ADP-ribosylation. This Thesis outlines the development of novel mono- and oligo-ADP-ribose derivatives and describes their use as molecular probes in interactomics screenings to facilitate a more detailed investigation of the proteins involved in ADP-ribosylation.<br>

Authors

Publication Details

Journal
Leiden Repository (Leiden University)
Published
2026-01-01
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthetic affinity-based probes for ADP-Ribose interactome studies

F.L.A.M. van der Heijden
Leiden Repository (Leiden University)
PARP inhibition in cancer therapy
article

Synthetic affinity-based probes for ADP-Ribose interactome studies

F.L.A.M. van der Heijden
article en

Abstract

Adenosine diphosphate ribosylation (ADP-ribosylation) is a fascinating post-translational modification (PTM) that plays a role in a variety of cellular processes and is associated with several diseases, including cancer and viral infections. To understand this PTM in more detail and consequently develop effective drugs based on this information, it is essential to investigate the key proteins involved in ADP-ribosylation: ADP-ribosyltransferases (<i>writers</i>), hydrolases (<i>erasers</i>), and the proteins interacting with ADP-ribose (<i>readers</i>). Much past and current research has examined proteins that function as the writers and erasers of ADP-ribosylation. This research has led to the development of anti-cancer drugs, such as olaparib, and advancements towards future antiviral therapies targeting COVID-19. However, there is also significant potential in exploring the readers of ADP-ribosylation, as they regulate many downstream processes related to ADP-ribosylated proteins and may present valuable therapeutic targets. To gain a better understanding of the readers of ADP-ribose as post-translational modification, it is essential to identify which proteins specifically interact with each of the various forms of ADP-ribose, including mono-ADP-ribose, linear poly-ADP-ribose, and branched poly-ADP-ribose. Well-defined synthetic ADP-ribose derivatives serve as ideal molecular probes in proteomics studies, allowing clear differentiation between the different forms of ADP-ribosylation. This Thesis outlines the development of novel mono- and oligo-ADP-ribose derivatives and describes their use as molecular probes in interactomics screenings to facilitate a more detailed investigation of the proteins involved in ADP-ribosylation.<br>

Leiden Repository (Leiden University)
Good health and well-being
Openalex Percentile: Top 11%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.